A Phase 2, Open-Label, Randomized, Parallel Group, Placebo-Controlled, Single-Center Study to Assess Anti-microbial Efficacy and Safety of DCN01 Compared to Unisol® Following Topical Periocular Administration in Healthy Volunteers
| Status: | Completed |
|---|---|
| Conditions: | Infectious Disease |
| Therapuetic Areas: | Immunology / Infectious Diseases |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/21/2016 |
| Start Date: | April 2013 |
| End Date: | July 2013 |
This proof-of-concept study evaluates the clinical efficacy and safety of DCN01 in prepping
of the periocular region.
of the periocular region.
Inclusion Criteria:
- Have given a written, informed consent
- Be willing and able to follow all instructions
- A negative urine pregnancy test if female of childbearing potential
Exclusion Criteria:
- Known sensitivities to study medication or its components
- Any signs of an active infection
- Use of disallowed products during the period indicated prior to the enrollment or
during the study
- Be currently pregnant, nursing, or planning a pregnancy; or be a woman that has a
positive pregnancy test
- Have a condition or a situation which, in the Investigator's opinion, may put the
subject at increased risk, confound study data, or interfere significantly with the
subject's study participation
We found this trial at
1
site
Click here to add this to my saved trials
